While originally considered a biomarker of myocardial injury in the setting of acute coronary syndromes, the emergence of refined immunoassays for the measurement of troponin now allows for identification of minute amounts of cardiac injury that in appropriate circumstances may identify heart stress, similar to the information gained from BNP or NT-proBNP measurement. Here, NPPB is linked to acute coronary syndrome.